Compare Transocean Ltd (RIG) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Transocean Ltd vs Zimmer Biomet Holdings Inc — how do they compare? Transocean Ltd trades at $5.3 (market cap $5.80B), while Zimmer Biomet Holdings Inc trades at $88.69 (market cap $17.20B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 3× Transocean Ltd's market cap, and Zimmer Biomet Holdings Inc pays a 1.08% dividend while Transocean Ltd pays none. Which is the better fit depends on your goals.
| RIG | ZBH | |
|---|---|---|
Market Cap | $5.80B | $17.20B |
Sector | Technology | Health |
52-Week High | $7.58 | $107.71 |
52-Week Low | $2.80 | $79.58 |
Enterprise Value | $10.74B | $24.25B |
Dividend Yield | — | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Transocean Ltd. (RIG) trades at $5.02, down 2.33% today, reflecting ongoing investor caution despite recent contract wins. The stock shows a bearish technical bias with moving averages signaling sell pressure, while fundamentals reveal persistent net losses (-$2.92B in 2025) despite high gross margins (84.88%). Recent news highlights a $1B+ Equinor contract and pending Valaris merger, boosting long-term revenue visibility but failing to offset near-term profitability concerns.
RIG's investment case hinges on backlog execution and merger synergies, offering potential upside to the $7.00 consensus target. However, high leverage, volatile oil prices, and consecutive earnings misses pose significant risks. Analyst sentiment is divided (39% Buy, 39% Hold), suggesting cautious optimism amid operational challenges.
Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.
The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
